Trials / Conditions / Blood Brain Barrier Defect

Blood Brain Barrier Defect

10 registered clinical trials studyying Blood Brain Barrier Defect — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Association Between Postoperative Inflammatory and Neurological Serum Biomarker Concentrations and Occurre NCT07411612	Medical University of Vienna	—
Unknown	The Relations Among Endotoxin, Inflammatory Cytokines, Cognitive Markers and Brain MRI Changes in Subjects Wit NCT06203015	Lithuanian University of Health Sciences	—
Unknown	MRI Study of Blood-brain Barrier Function in CADASIL NCT05902039	Peking University First Hospital	—
Withdrawn	The Importance of Sleep Quality and the Blood-brain Barrier in Cognitive Disorders and Alzheimer's Disease NCT04096261	Charite University, Berlin, Germany	—
Active Not Recruiting	Minocycline for Aneurysmal Subarachnoid Hemorrhage (MASH) NCT04876638	University of Southern California	Phase 2
Completed	Endothelial Injury Mechanism in Elderly Patients Undergoing Major Surgery NCT03639896	The First Affiliated Hospital of Anhui Medical University	Phase 4
Completed	Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) NCT03996447	Guerbet	Phase 3
Completed	Microvascular Injury and Blood-brain Barrier Dysfunction as Novel Biomarkers and Targets for Treatment in Trau NCT03139682	Nova Scotia Health Authority	—
Completed	P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI) NCT02633501	Guerbet	Phase 2
Completed	Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration NCT02389738	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	EARLY_Phase 1